baber/WOPTO huggingface dataset:
Patent FI-940827-A0 (FI)
Inventor: BECK JOSEF
IPC: F16D55/00
Filed: 1994-02-22
Abstract: PCT No. PCT/EP92/01611 Sec. 371 Date Jun. 20, 1994 Sec. 102(e) Date Jun. 20, 1994 PCT Filed Jul. 16, 1992 PCT Pub. No. WO93/04281 PCT Pub. Date Mar. 4, 1993.An axial piston motor of adjustable swept volume for installation in a wheel hub, having a motor housing which is open on one side and is closed by a connection block, an output shaft rotatably mounted in the housing and a connection block, an adjusting device for adjusting the swept volume, a step-down gear unit driven by the output shaft and having a driving toothed wheel for the drive of the wheel hub, and a brake associated with the output shaft on the connection block. For the purpose of reducing the outlay in terms of construction, with comparatively compact dimensions, and for greater ease of external access to the adjusting device, the step-down gear unit (13) is arranged inside the motor housing (1, 3) with two-sided mounting of the driving toothed wheel (47) and the connection block (5) is set back radially with respect to the motor housing (1) and the adjusting device (28, 29, 30) is arranged so as to be freely externally accessible in the region (23) of the motor housing (1, 2) that is free of covering.
Patent FI-942030-A0 (FI)
Inventor: MEIXNER JUERGEN
IPC: C09D7/43
Filed: 1994-05-03
Abstract: A lacquer composition which can be cured by a free-radical mechanism and essentially comprises   A) from 50 to 95 parts by weight of an unsaturated polyester component having a viscosity at 23@C of from 1000 to 15000 mPa.s, B) from 5 to 50 parts by weight of compounds containing (meth)acrylic groups and/or vinyl ether groups, and C) from 0.01 to 0.3% by weight, based on the overall weight, of waxes and/or paraffins having a melting point of from 35 to 100@C, D) from 0 to 10% by weight, based on the overall weight, of at least one plasticiser resin or carbamic acid resin, and also, if desired, E) other auxiliaries and additives which are known from the technology of the unsaturated polyester resins; and the use of the lacquer composition as a free-radically curable furniture varnish.
Patent FI-946060-A0 (FI)
Inventor: ATTENBERGER THOMAS
IPC: B05B7/14
Filed: 1994-12-23
Abstract: In a process for providing security papers with authenticity features, a homogeneous mixture of a feature material which is present in powder form and a gas in a defined concentration is produced. This mixture is ejected at high velocity from at least one nozzle arranged at a predetermined distance from the paper web and is transferred to the running paper web. <IMAGE>
Patent FI-953818-A0 (FI)
Inventor: THOMSEN OVE LYCK
IPC: G05F1/00
Filed: 1995-08-11
Abstract: PCT No. PCT/DK94/00060 Sec. 371 Date Sep. 28, 1995 Sec. 102(e) Date Sep. 28, 1995 PCT Filed Feb. 11, 1994 PCT Pub. No. WO94/18739 PCT Pub. Date Aug. 18, 1994An emergency power system is connected between an AC voltage source and a load. The emergency power system ensures a stable voltage on the output, even if the AC voltage received from the AC voltage source is irregular or is interrupted briefly. The emergency power system includes an AC/DC converter coupled between the load terminals and an AC regulator positioned between the AC voltage source and the load. The AC/DC converter is coupled to a chargeable battery and serves as a charging rectifier for the battery in normal operation and as an inverter in emergency operation, the battery voltage being converted to AC voltage on the output of the emergency power system. The AC regulator is built as a controllable current generator supplying on its output an AC current which is in phase with the AC voltage received from the AC voltage source. Irrespective of the energy direction through it, the AC/DC converter maintains the predetermined AC voltage (VOUT) across the output terminals of the emergency power system. The system includes a comparator which senses and compares the battery state to a predetermined reference and supplies a signal in response to this. The intensity of the current supplied by the AC regulator is controlled in response to the signal generated by the comparator so that in terms of energy the system is in power balance.
Patent FI-955033-A0 (FI)
Inventor: JAUHOLA LAURI
IPC: F15B21/12
Filed: 1995-10-23
Abstract: PCT No. PCT/FI96/00299 Sec. 371 Date Nov. 28, 1997 Sec. 102(e) Date Nov. 28, 1997 PCT Filed Mar. 27, 1996 PCT Pub. No. WO96/38673 PCT Pub. Date Dec. 5, 1996The object of the invention is a method in a pneumatic oscillating device for observing an obstacle within the length of the work stroke and continuing the oscillating movement after this. The oscillating device includes a double-acting operating cylinder (1), a principal operating valve (6) controlling this, and a reversing valve (4), by which the principal operating valve (6) is controlled. A resistance to the flow on whichever return line (1.31, 1.41) of the operating cylinder (1) is in use, is arranged in order to maintain the return side pressure of the operating cylinder (1) at a level that is clearly higher than the ambient pressure during a work stroke in a normal situation, and sensing the pressure of the return side and, if it drops below a set limit, which is indicated by the movement of the pressure slowing or stopping completely, giving a command to the reversing valve (4) to change direction on the basis of this.
Patent FI-955219-A0 (FI)
Inventor: MICHEL HARTMUT
IPC: H01G2/04
Filed: 1995-11-01
Abstract: The electrolytic capacitor is built-into a metallic housing which has a fixing bung (2) at the base with whose help the capacitor is fixed so as to be secure against vibration on a fixing plate (3). The fixing bung is fixed by a snap mounting (5) of an insulating material. The snap mounting is pressed into a bore hole (4) in the fixing plate. A protrusion (6) is arranged on the snap mounting which presses the snap mounting onto the fixing plate. The fixing bung has a constriction (13) in which parts on the snap mounting engage.
Patent FI-971610-A0 (FI)
Inventor: SCHERKENBECK JUERGEN
IPC: C07D273/00
Filed: 1997-04-16
Abstract: PCT No. PCT/EP95/03926 Sec. 371 Date Apr. 10, 1997 Sec. 102(e) Date Apr. 10, 1997 PCT Filed Oct. 5, 1995 PCT Pub. No. WO96/11945 PCT Pub. Date Apr. 25, 1996The present invention relates to a process for the aromatic sulfonylation, sulfenylation, thiocyanation and phosphorylation of cyclic depsipeptides having 6 to 24 ring atoms which are synthesized from  alpha -hydroxycarboxylic acids and  alpha -amino acids and contain at least one phenyl radical, characterized in that these cyclic depsipeptides are reacted with sulfonylating, sulfenylating, thiocyanating or phosphorylating agents, optionally in the presence of catalysts, auxiliaries and/or diluents, to novel thus-obtained compounds, and to their use as endoparasiticides.
Patent FI-972865-A0 (FI)
Inventor: BORER RENE
IPC: A61P21/02
Filed: 1997-07-04
Abstract: The invention is concerned with hydroxymethyl-imidazodiazepines and their esters of general formula I. These compounds can be used as anxiolytic and/or anticonvulsant and/or muscle relaxant and/or sedative-hypnotic active substances.
Patent FI-981399-A0 (FI)
Inventor: LAHTINEN PASI
IPC: H04M3/38
Filed: 1998-06-16
Abstract: A system and method for controlling telephone voting in a digital mobile communication network that includes a plurality of mobile subscriber communication stations provides for automated, statistically-appropriate control of telephonic voting via such mobile stations. Using a polling server, a predetermined initial proportion of the mobile stations is authorized to concurrently transmit a vote by transmitting a voting authorization to the authorized mobile stations over a control channel from the polling server. A voting application stored in or associated with each mobile station monitors the control channel and enables transmission of a vote from a mobile station only after the authorization has been received by that mobile station. The invention thereby accommodates and assures the staggered transmission of votes in a telephonic poll so as to avoid overloading of the network.
Patent FI-981977-A0 (FI)
Inventor: YLITALO JUHA
IPC: H04B7/08
Filed: 1998-09-14
Abstract: The invention relates to a RAKE receiver of a CDMA system using IRC, the receiver receiving a radio signal by using at least two antenna branches. In accordance with the invention a RAKE finger comprises: a weighting coefficient part for forming weighting coefficients maximizing the Signal-to-Interference-and-Noise Ratio for each antenna branch; a multiplier for multiplying a pilot part, despread by a despreader in each antenna branch, by a weighting coefficient; a multiplier for multiplying a data part, despread by a despreader in each antenna branch, by a weighting coefficient; an antenna branch summer for combining the despread pilot parts, received via the separate antenna branches and multiplied by the weighting coefficient, to one pilot signal; an antenna branch summer for combining the despread data parts, received via the separate antenna branches and multiplied by the weighting coefficient, to one data signal. In addition, the receiver comprises a RAKE finger summer for combining the data signals of the RAKE fingers operating by different delays to a sum data signal representing the received bits.
Patent IL-67040-A0 (IL)
Title: New n-nitroso-n-(beta-chloro ethyl)-carbamoyl peptides
IPC: A61K38/00
Filed: 1982-10-21
Abstract: Compounds of the general Formula I
 [Cl-CH2-CH2-@@CO-NH]nR (I)
 wherein
 R is a group derived from any oligopeptide by removing a terminal amino group, or - if the oligopeptide comprises a diamino carboxylic acid - the amino group in the  omega -position, or the terminal and  omega -amino groups; and
 n stands for the integral number 1 or 2
 and acid addition salts thereof and a process for the preparation thereof. 
<??>The new compounds of the general Formula I exhibit antitumor activity.
Patent IL-72330-A0 (IL)
Title: Triazolo-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/505
Filed: 1984-07-06
Abstract: This invention relates to triazolo-pyrimidine derivatives corresponding to the following formula:    <IMAGE>  I  wherein X represents a 2-pyridyl, 3-pyridyl or 4-pyridyl nucleus optionally substituted by at least one straight-chained or branched C1-4 alkoxy or alkyl or a hydroxy or cyano group, R1 represents hydrogen or a straight-chained or branched saturated or unsaturated C1-5 aliphatic group, and R2 represents a straight-chained or branched C1-4 alkyl group, and the pharmaceutically acceptable acid addition salts thereof with inorganic or organic acids. These compounds may be used in therapy, particularly on account of their cardiotonic activity.
Patent IL-76932-A0 (IL)
Title: Pharmaceutical compositions containing dihydrocodeine and ibuprofen
IPC: A61K31/47
Filed: 1985-11-04
Abstract: Pharmaceutical compositions containing dihydrocodeine or a pharmaceutically acceptable acid addition salt thereof and ibuprofen or a pharmaceutically acceptable salt thereof are useful in treating pain in mammals.
Patent IL-84252-A0 (IL)
Title: Phospholipase inhibiting compositions
IPC: A61K31/685
Filed: 1987-10-23
Abstract: Inhibitors of phospholipase A2 activity at the cell-surface membrane whose molecular structure comprises a cell-permeable PLA2-inhibitor moiety covalently bonded directly or indirectly to a physiologically acceptable carrier moiety which is effective to inhibit cell internalisation of the cell-permeable PLA2-inhibitor moiety, with the proviso that phosphatidylserine is not bonded indirectly via divalent dodecanedioyl to dextrane hydrazide.
Patent IL-90356-A0 (IL)
Title: Amphiphilic peptides and pharmaceutical compositions containing them
IPC: C07K7/06
Filed: 1989-05-19
Abstract: Amphiphilic biologically active peptides and intermediates. For example, the polypeptide comprises a chain of at least four groups of four amino acids. In each group of four amino acids, two amino acids are hydrophobic, one amino acid is basic hydrophilic, and the remaining amino acid is basic or neutral hydrophilic. A preferred amino acid sequence is Ala-Phe-Ser-Lys.
Patent IL-99512-A0 (IL)
Title: Calcium uptake inhibitors
IPC: C07D233/14
Filed: 1991-09-17
Abstract: This invention relates to 1-phenyl-3-aryl-2-propyne-1-ones and pharmaceutical compositions containing these compounds as active ingredients useful as calcium uptake inhibitors in leukocytes and the process of their preparation.
Patent AU-PR435501-A0 (AU)
Title: Network security system
IPC: H04L29/06
Filed: 2001-04-11
Abstract: A network security device that does not require a separate computer for implementation is disclosed. The device may be in the form of a boxed hardware component and may be configured from an HTML interface. The device contains and uses three network cards. The first two cards are used for the firewall. A third card is a management interface having a private, non publicly routed IP address. A first network card forwards packets to a packet filter. Packets which pass the packet filter are then forwarded to a second network card and subsequently to their destination. None of the three network cards have a publicly routed IP address. The device acts as a packet filter that bridges rather than routes or proxies. The device may be connected between a router and a hub or a server machine.
Patent FI-20002721-A0 (FI)
Inventor: KULOJAERVI TAUNO
IPC: B62D21/02
Filed: 2000-12-12
Abstract: The invention relates to a vehicle chassis, a fastening arrangement and a fixing piece. Longitudinal beams (1) and transverse beams (2) of a vehicle are arranged on different levels relative to each other, and thereby, as distinct from prior art chassis structures, the transverse beams may extend as uniform pieces from a first side of the vehicle to its second side. At the intersection of a longitudinal beam and a transverse beam there is provided a plate-like fixing piece (5) separately fastened to both of the intersecting chassis beams and transferring the forces between the beams.
Patent IL-102853-A0 (IL)
Title: Olefin polymer based thermoplastic elastomers comprising zinc-salts of certain mercapto compounds and hindered phenols for improved heat aging
IPC: C08L23/16
Filed: 1992-08-18
Abstract: Disclosed is an olefin polymer-based thermoplastic elastomer comprising a propylene polymer material, an amorphous olefin copolymer rubber, and optionally a semicrystalline, essentially linear ethylene-C3-4 alpha-olefin copolymer, having incorporated therein zinc salts of certain mercapto compounds and sterically hindered di-tertiary butyl phenol compounds. The compositions exhibit good retention of properties at elevated temperatures.
Patent IL-105172-A0 (IL)
Title: Enzyme and a dna sequence
IPC: C12N9/18
Filed: 1993-03-26
Abstract: PCT No. PCT/DK93/00109 Sec. 371 Date Oct. 5, 1994 Sec. 102(e) Date Oct. 5, 1994 PCT Filed Mar. 29, 1993 PCT Pub. No. WO93/20190 PCT Pub. Date Oct. 14, 1993The present invention relates to rhamnogalacturon acetyl esterases derived from Aspergillus aculeatus and DNA Sequences encoding the enzymes. The present invention also relates to the use of rhamnogalacturon acetyl esterases for degrading modified hairy region.
Patent IL-110436-A0 (IL)
Title: Tricyclic benzazepine vasopressin antagonists
IPC: C07D498/04
Filed: 1994-07-25
Abstract: Tricyclic compounds of the general Formula I: <CHEM> as defined herein which exhibit antagonist activity at V1 and/or V2 receptors and exhibit in vivo vasopressin antagonist activity, methods for using such compounds in treating diseases characterized by excess renal reabsorption of water, and processes for preparing such compounds.
Patent IL-118240-A0 (IL)
Title: Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
IPC: A61P1/04
Filed: 1996-05-13
Abstract: Inflammatory bowel disease, especially Crohn's disease and ulcerative colitis, is treated by administration of an oral dosage form, containing as an active principle an omega-3 polyunsaturated acid in free acid form or as a pharmaceutically acceptable salt thereof, which releases the acid in the ileum. Preferably the oral dosage form is a gelatine capsule coated with a poly(ethylacrylate-methylmethacrylate).
Patent IL-119462-A0 (IL)
Title: Pyrrolopyrimidines
IPC: A61P3/00
Filed: 1996-10-21
Abstract: The compounds of the formulawherein R1, R2, R3, R4, R5 and R6 are as defined herein, are useful in the treatment of stress-related and other diseases. These compounds have corticotropin-releasing factor antagonist activity and as such are of use in the treatment of stress and anxiety related, and other disorders.
Patent IL-121787-A0 (IL)
Title: Process for the preparation of disodium Z-L-aspartate from fumaric acid
IPC: C07K5/06
Filed: 1997-09-17
Abstract: Preparation of disodium Z-L-aspartate (I) (where Z = benzyloxycarbonyl) from fumaric acid (II) involves: (a) reacting (II) with ammonia, in an inert diluent in presence of aspartase or a microorganism producing aspartase, to give ammonium L-aspartate (III); (b) treating the (III)-containing solution with sodium hydroxide in an amount producing mono- and/or disodium L-aspartate (IV); (c) recycling the ammonia formed into a suspension of (II) for use as starting material for further enzymatic conversion; and (d) reacting the remaining solution containing (IV) with benzyloxycarbonyl chloride (SZ-Cl) at pH 9-14, with simultaneous addition of NaOH, to give (I).
Patent IL-124375-A0 (IL)
Title: Stable biotinylated biomolecule composition and methods for preparing the same
IPC: C07K14/75
Filed: 1996-10-24
Abstract: Stable compositions containing biotinylated molecules, such as enzymes, are provided. The compositions include a biotinylated biomolecule, a biomolecule protectant, a buffer, a bulking agent selected from one or more water soluble, nonionic polymers and preferably a terminal sterilization protectant. The compositions can be utilized either as aqueous solutions or preferably in dried form, e.g., as a lyophilized, powder cake. They have applicability in any case where avidin/biotin technology is used and are particularly important as compositions containing a thrombin-like enzyme, e.g., for preparation of a fibrin monomer and fibrin monomer-based fibrin sealants.
Patent IL-129117-A0 (IL)
Title: Process and system for interactive communication between two telephone apparatuses via the internet network
IPC: H04L12/64
Filed: 1997-09-25
Abstract: The invention concerns a method and system for interactive communication between at least two users each provided with a telephone set of the switched telephone network, via the Internet. Each telephone set is directly locally connected to an associated interface device. The first user, who initiates the communication, dials on his set the telephone number of the second user indicating to his interface device that he wishes to communicate via the Internet. The interface device of the first user the connects with the interface device of the second user via the Internet, the two telephone sets being rung off. Once the connection has been established via the Internet, each interface device indicates to its associated telephone set, then each of the users picks up his set and communicates interactively with his correspondent via the Internet.
Patent IL-129992-A0 (IL)
Title: Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
IPC: A61K31/40
Filed: 1999-05-17
Abstract: Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in the affected joint of a mammal is accomplished by administering a chondroprotective compound of Formula (I): <CHEM>  wherein <CHEM> where A is hydroxy, (C1 - C4)alkoxy, amino, hydroxy-amino, mono-(C1 -C2)alkylamino, di-(C1-C2)alkylamino; X and Y are independently H or (C1 - C2)alkyl; and n is 1 or 2; R<6> is halogen, (C1 - C3)alkyl, trifluoromethyl, or nitro; R<9> is H; (C1 - C2)alkyl; phenyl or phenyl-(C1 - C2)alkyl, where phenyl is optionally mono-substituted by fluoro or chloro; -C(=O)-R, where R is (C1-C2)alkyl or phenyl, optionally mono-substituted by fluoro or chloro; or -C(=O)-O-R<1> , where R<1> is (C1 - C2)alkyl. This treatment ameliorates, diminishes, actively treats, reverses or prevents any injury, damage or loss of articular cartilage or subchondral bone subsequent to said early stage of said degeneration. Whether or not a mammal needs such treatment is determined by whether or not it exhibits a statistically significant deviation from normal standard values in synovial fluid or membrane from the affected joint, with respect to at least five of the following substances: increased interleukin-1 beta (IL-1 beta ); increased tumor necrosis factor alpha (TNF alpha ); increased ratio of IL-1 beta  to IL-1 receptor antagonist protein (IRAP); increased expression of p55 TNF receptors (p55 TNF-R); increased interleukin-6 (IL-6); increased leukemia inhibitory factor (LIF); decreased insulin-like growth factor-1 (IGF-1); decreased transforming growth factor beta (TGF beta ); decreased platelet-derived growth factor (PDGF); decreased basic fibroblast growth factor (b-FGF); increased keratan sulfate; increased stromelysin; increased ratio of stromelysin to tissue inhibitor of metalloproteases (TIMP); increased osteocalcin; increased alkaline phosphatase; increased cAMP responsive to hormone challenge; increased urokinase plasminogen activator (uPA); increased cartilage oligomeric matrix protein; and increased collagenase.
Patent IL-136314-A0 (IL)
Title: Integrin receptor antagonists
IPC: A61P27/02
Filed: 1998-12-14
Abstract: The present invention relates to compounds and derivatives thereof, their synthesis, and their use as integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors  alpha v beta 3,  alpha v beta 5 and/or  alpha v beta 6 and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, wound healing, viral disease, and tumor growth and metastasis.
Patent IL-144702-A0 (IL)
Title: Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2, 8 diazabicyclo-[4.3.0.] nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
IPC: C07D471/04
Filed: 2000-02-14
Abstract: The present invention relates to a defined crystal modification of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid of the formula (1), to processes for its preparation and to its use in pharmaceutical preparations.The crystal modification can be distinguished from other crystal modifications of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid of the formula (1) by its characteristic X-ray powder diffractogram and its differential thermodiagram (see description).
Patent IL-181286-A0 (IL)
Title: Methods of healing wounds by administering human il-18
Filed: 2007-02-12
Abstract: The present invention relates generally to the use of human IL-18, also known as interferon-³-inducing factor (IGIF), in the treatment of skin wounds, surgical wounds, leg ulcers, diabetic ulcers, gastrointestinal mucositis, oral mucositis, and lung injury.